Episode Details

Please visit answersincme.com/MVB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology and a patient advocate discuss strategies to optimize care for patients with metastatic breast cancer using antibody-drug conjugates. Upon completion of this activity, participants should be better able to: Identify the rationale for targeted antibody-drug conjugates (ADCs) in the treatment of patients with metastatic breast cancer (mBC); Review strategies to enhance safety of the available ADCs for the treatment of mBC; and Outline patient-focused strategies to optimize the use of ADCs in appropriate patients with mBC.